• Galectin Therapeutics Inc., of Norcross, Ga., said it established a drug discovery program in collaboration with Geert-Jan Boons' lab at the University of Georgia to discover new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role, including cancer and inflammatory and fibrotic disorders.